GE Healthcare Extends Use of PTC® Solutions to Include Arbortext® Dynamic Publishing Software; PTC Life Sciences Solution Drives Productivity Improvements and Streamlines Communication

Business Wire, August 7, 2006

NEEDHAM, Mass. -- PTC (Nasdaq: PMTC), the Product Development Company(TM), today announced that GE Healthcare, a unit of General Electric Company (NYSE: GE), has extended its use of PTC solutions to include PTC Arbortext, in order to dynamically publish product documentation. The selection of Arbortext extends GE Healthcare's existing relationship with PTC as a longtime user of Pro/ENGINEER(R) and Windchill PDMLink(R).

GE Healthcare selected Arbortext because they required a dynamic publishing solution that would help ensure its product documentation was available when new products are released to market. Arbortext software gives GE content authors the ability to create and collaborate on product documentation. GE Healthcare hopes to improve author productivity, reduce publishing costs and slash time to market for new and existing products through streamlined cross-departmental communication processes.

"An inefficient publishing process can delay the delivery of new products to market and damage customer satisfaction," said Maria Caduto, information architect and team lead, technical publications, GE Healthcare. "Using PTC we have improved the publishing process to minimize product delays. We chose PTC because of their technical expertise and continued commitment to improving business processes that help us remain competitive."

In addition to the technical publications group at GE Healthcare using PTC Arbortext to dynamically publish its product documentation, its clinical systems engineering teams have been using PTC's Product Development System (PDS) to connect their design communities located across seven worldwide development sites. PTC's PDS, which includes Pro/ENGINEER and Windchill PDMLink, enables efficient and cost-effective product design processes that reduce product design costs and improves time to market for new products.

"PTC's success in the life sciences market reflects our commitment to working with customers like GE Healthcare to understand and meet unique business requirements," said Josh Fredberg, vice president of product and market strategy, PTC. "The integration between Pro/ENGINEER, Windchill and Arbortext allows life sciences companies to optimize their product documentation process, enabling them to remain leaders in the market."

Today, eight of the world's top ten medical products suppliers, 10 of the world's top 15 pharmaceuticals companies and three of the top five OEM's rely on PTC for their product solutions. Using PTC's superior PDS, life science companies are able to develop better quality, lower-cost products faster, and streamline their introduction into the marketplace.

About GE Healthcare

GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, performance improvement, drug discovery, and biopharmaceutical manufacturing technologies is helping clinicians around the world re-imagine new ways to predict, diagnose, inform and treat disease, so their patients can live their lives to the fullest.

GE Healthcare's broad range of products and services enable healthcare providers to better diagnose and treat cancer, heart disease, neurological diseases, and other conditions earlier. Our vision for the future is to enable a new "early health" model of care focused on earlier diagnosis, pre-symptomatic disease detection and disease prevention. Headquartered in the United Kingdom, GE Healthcare is a $15 billion unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employs more than 43,000 people committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at http://www.gehealthcare.com.

About PTC Solutions for Life Sciences

PTC solutions for life sciences are designed to meet the product lifecycle management requirements of medical device, pharmaceutical and medical equipment manufacturers. These solutions include product development process and data management, electronic verification and collaboration, authenticated electronic signatures and 3D mechanical design. PTC has over 500 medical products customers, including the top manufacturers across the globe.

About PTC

PTC (Nasdaq: PMTC) provides leading product lifecycle management (PLM), content management and dynamic publishing solutions to more than 40,000 companies worldwide. PTC customers include the world's most innovative companies in manufacturing, publishing, services, government and life sciences industries. PTC is included in the S&P 500 and Russell 2000 indices. For more information on PTC, please visit http://www.ptc.com.

Except for the historical information contained herein, matters discussed in this news release may constitute forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those projected. These risks and uncertainties include: the successful development and integration of the technology necessary to offer integrated solutions that adequately responds to the evolving product lifecycle management and regulatory requirements of customers within the life sciences industry; PTC's ability to extend our solutions, including the Arbortext suite of solutions, to vertical industries beyond the discreet manufacturing verticals traditionally served by PTC; PTC's ability to retain and maintain relationships with key Arbortext employees, customers and other strategic partners, including those within markets and vertical industries with which PTC has little experience; and the market for, and customer adoption of, dynamic enterprise publishing may not grow as quickly as PTC expects, as well as other risks and uncertainties detailed from time to time in reports filed by PTC with the Securities and Exchange Commission, including the Company's most recent reports on Form 10-K and 10-Q. The announcement of any particular selection of PTC products is not necessarily indicative of the timing of recognition of revenue there from or the level of revenue for any particular period.